AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2010
Feb 23, 2010
35124_dirs_2010-02-23_d9cdb622-0311-4683-aa8e-93d4c3ec5a89.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2010-02-19
Reporting Person: Tardugno Michael H (Chief Executive Offier)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-02-19 | Common Stock (Bonus Grant) | A | 17412 | $2.94 | Acquired | 89328 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-19 | Common Stock Option | $2.94 | A | 85000 | Acquired | 2020-02-19 | Celsion Common Stock (85000) | Direct |
Footnotes
F1: Fair Value on date of grant award.
F2: Stock Grant issued in lieu of cash bonus.
F3: Option vest 1/3 each on February 19, 2011, 2012 and 2013.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18